Table 1 List of FDA-approved drugs for breast cancer treatment
From: Computationally repurposing drugs for breast cancer subtypes using a network-based approach
Abemaciclib | Kadcyla (Ado-Trastuzumab Emtansine) |
Abitrexate (Methotrexate) | Kisqali (Ribociclib) |
Abraxane (Paclitaxel Albumin-stabilized Nanoparticle Formulation) | Lapatinib Ditosylate |
Ado-Trastuzumab Emtansine | Letrozole |
Afinitor (Everolimus) | Lynparza (Olaparib) |
Anastrozole | Megestrol Acetate |
Aredia (Pamidronate Disodium) | Methotrexate |
Arimidex (Anastrozole) | Methotrexate LPF (Methotrexate) |
Aromasin (Exemestane) | Mexate (Methotrexate) |
Capecitabine | Mexate-AQ (Methotrexate) |
Clafen (Cyclophosphamide) | Neosar (Cyclophosphamide) |
Cyclophosphamide | Neratinib Maleate |
Cytoxan (Cyclophosphamide) | Nerlynx (Neratinib Maleate) |
Docetaxel | Nolvadex (Tamoxifen Citrate) |
Doxorubicin Hydrochloride | Olaparib |
Ellence (Epirubicin Hydrochloride) | Paclitaxel |
Epirubicin Hydrochloride | Paclitaxel Albumin-stabilized Nanoparticle Formulation |
Eribulin Mesylate | Palbociclib |
Everolimus | Pamidronate Disodium |
Exemestane | Perjeta (Pertuzumab) |
5-FU (Fluorouracil Injection) | Pertuzumab |
Fareston (Toremifene) | Ribociclib |
Faslodex (Fulvestrant) | Tamoxifen Citrate |
Femara (Letrozole) | Taxol (Paclitaxel) |
Fluorouracil Injection | Taxotere (Docetaxel) |
Folex (Methotrexate) | Thiotepa |
Folex PFS (Methotrexate) | Toremifene |
Fulvestrant | Trastuzumab |
Gemcitabine Hydrochloride | Tykerb (Lapatinib Ditosylate) |
Gemzar (Gemcitabine Hydrochloride) | Velban (Vinblastine Sulfate) |
Goserelin Acetate | Velsar (Vinblastine Sulfate) |
Halaven (Eribulin Mesylate) | Verzenio (Abemaciclib) |
Herceptin (Trastuzumab) | Vinblastine Sulfate |
Ibrance (Palbociclib) | Xeloda (Capecitabine) |
Ixabepilone | Zoladex (Goserelin Acetate) |
Ixempra (Ixabepilone) | Â |